-
In a Restless Preclinical Testing Market, Organs-on-Chips Company MIMETAS Is in Expansion Mode
Bio-IT World | Dutch startup MIMETAS, whose microfluidics technology forms a platform for three-dimensional, multi-cell-type tissue cultures, is securing new funding and partnerships as it expands its line of drug screening models.
Oct 31, 2014
-
Expanding the Search for Knockout Mutations to the Human Population
Nature News | With mass sequencing of humans now a practical reality, several large population studies are searching for people with rare mutations that completely knock out specific genes, to uncover these genes' functions and potentially new drug targets.
Oct 29, 2014
-
Large Funding Round for Massachusetts Biotech Syros
Xconomy | Syros Pharmaceuticals, a biotech focused on creating drugs that target gene expression regulatory pathways, has announced a $53 million Series B financing round.
Oct 27, 2014
-
The Peculiar Internet Market for Genetic Health Reports
MIT Technology Review | Since the FDA made clear last November that it would not tolerate companies selling genetic tests linked to health reports without regulatory approval, a workaround for customers of companies like 23andMe has emerged online.
Oct 24, 2014
-
New Microscopy Technique Offers Astounding Resolution Over Time
Bio-IT World News Brief | A paper published today in Science describes a new type of fluorescence microscope that is capable of taking images of living, three-dimensional systems over long periods of time without degrading cells or fluorescent molecules.
Oct 23, 2014
-
Inside the HIVE, the FDA's Multi-Omics Compute Architecture
Bio-IT World | At the FDA's Center for Biologics Evaluation and Research, a custom distributed computing system called HIVE takes a new approach to storing and analyzing huge sets of genomic and other biological data.
Oct 22, 2014
-
New Data and Deployments from Edico Genome
Bio-IT World News Brief | Edico Genome, a San Diego-based company manufacturing application-specific integrated circuits for processing genomic data, this week announced the broad commercial launch of its flagship DRAGEN processor.
Oct 21, 2014
